ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123

The present invention concerns antibody-like binding protein specifically binding to CD3 and binding specifically to at least one further antigen, for example CD123. The present invention also concerns antibody-like binding protein specifically binding to CD123 and binding specifically to at least o...

Full description

Saved in:
Bibliographic Details
Main Authors LEUSCHNER, Wulf-Dirk, WONEROW, Peter, CARREZ, Chantal, ALBRECHT, Jana, WETZEL, Marie-Cécile, BARRIERE, Cédric, GUERIF, Stéphane, KROLL, Katja, LANGE, Christian, SCHNEIDER, Marion, BEIL, Christian, LEMOINE, Cendrine, RAO, Ercole, BENINGA, Jochen
Format Patent
LanguageEnglish
Published 30.08.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract The present invention concerns antibody-like binding protein specifically binding to CD3 and binding specifically to at least one further antigen, for example CD123. The present invention also concerns antibody-like binding protein specifically binding to CD123 and binding specifically to at least one further antigen. The invention further concerns anti-CD3 antibodies and anti-CD123 antibodies. The invention also relates to pharmaceutical compositions comprising the antibody-like binding protein, anti-CD3 antibodies or anti-CD123 antibodies of the invention, and their use to treat cancer. The invention further relates to isolated nucleic acids, vectors and host cells comprising a sequence encoding said antibody-like binding protein, anti-CD3 or anti-CD123 antibody and the use of said anti-CD123 antibody as a diagnostic tool.
AbstractList The present invention concerns antibody-like binding protein specifically binding to CD3 and binding specifically to at least one further antigen, for example CD123. The present invention also concerns antibody-like binding protein specifically binding to CD123 and binding specifically to at least one further antigen. The invention further concerns anti-CD3 antibodies and anti-CD123 antibodies. The invention also relates to pharmaceutical compositions comprising the antibody-like binding protein, anti-CD3 antibodies or anti-CD123 antibodies of the invention, and their use to treat cancer. The invention further relates to isolated nucleic acids, vectors and host cells comprising a sequence encoding said antibody-like binding protein, anti-CD3 or anti-CD123 antibody and the use of said anti-CD123 antibody as a diagnostic tool.
Author LANGE, Christian
KROLL, Katja
BEIL, Christian
WONEROW, Peter
ALBRECHT, Jana
SCHNEIDER, Marion
GUERIF, Stéphane
LEMOINE, Cendrine
RAO, Ercole
BENINGA, Jochen
CARREZ, Chantal
BARRIERE, Cédric
LEUSCHNER, Wulf-Dirk
WETZEL, Marie-Cécile
Author_xml – fullname: LEUSCHNER, Wulf-Dirk
– fullname: WONEROW, Peter
– fullname: CARREZ, Chantal
– fullname: ALBRECHT, Jana
– fullname: WETZEL, Marie-Cécile
– fullname: BARRIERE, Cédric
– fullname: GUERIF, Stéphane
– fullname: KROLL, Katja
– fullname: LANGE, Christian
– fullname: SCHNEIDER, Marion
– fullname: BEIL, Christian
– fullname: LEMOINE, Cendrine
– fullname: RAO, Ercole
– fullname: BENINGA, Jochen
BookMark eNrjYmDJy89L5WTIdfQL8dR1djFWADGc_F08XYN1FKCChkbIwkCmi4KTZ3CAq7Onm6czsgxMzNHHJxKoxM_F089dIcRfAWKui75_kALYNB4G1rTEnOJUXijNzaDi5hri7KGbWpAfn1pckJicmpdaEh_sbmhoZGBobmBqaWQa4GhMpDIABtE4mw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID SG11201705925PA
GroupedDBID EVB
ID FETCH-epo_espacenet_SG11201705925PA3
IEDL.DBID EVB
IngestDate Fri Oct 04 05:02:17 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_SG11201705925PA3
Notes Application Number: SG20171105925P
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170830&DB=EPODOC&CC=SG&NR=11201705925PA
ParticipantIDs epo_espacenet_SG11201705925PA
PublicationCentury 2000
PublicationDate 20170830
PublicationDateYYYYMMDD 2017-08-30
PublicationDate_xml – month: 08
  year: 2017
  text: 20170830
  day: 30
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies SANOFI
RelatedCompanies_xml – name: SANOFI
Score 3.1109443
Snippet The present invention concerns antibody-like binding protein specifically binding to CD3 and binding specifically to at least one further antigen, for example...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170830&DB=EPODOC&locale=&CC=SG&NR=11201705925PA
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8JAEJ4gGvWmqPGF6YH0ZEOB0rKHxtDdFmqgbaAaPJG-SDxQiNT4951di-JFb7Mzm8nuJLPz7WNmARqGThYY-GJl0dMihX9vrEREw12rQUiMeHYRd3nu8NjTh0_a46w7q8Bymwsj6oR-iOKI6FEJ-nsh1uv1zyEWE28rN834FVmrByc0mVzujlsGIgpVZpZpBz7zqUypOR3I3sREWCEqx5B2N-jvwT5H0rzUvv1s8cSU9W5UcU7gIECFeXEKlSyvwRHdfr5Wg8NxeeeNZOl-mzNY9r3QVSjrSJywfI7l7qWSicFhh40kkyx3GtjUdVy6K9ny-qPRC3bxmOsNpNCXvvSypj-RhLZzaDh2SIcKjnv-baf5dPBrlp0LqOarPLsEKYlIlmotkuHap6HH9VJDjdK2buhJm6hpfAX1P1Vd_yO_gWPeEmet6i1Ui7f3rI7BuojvhIk_AY1njHw
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR3LTsJAcIJoxJuixhe6B9KTDQVKyx4aQ3cpVEvbQDV6Ii0tiQcKkRp_3-laFC96m8xsJruTzGt3Zwagrmt0jo4vkuddNZTz8cZySFXMWnVKI4xn51Enrx0eudrwUb1_7jyXYLGphRF9Qj9Ec0TUqBnqeybs9ernEouLv5XrRvSKqOWdFRhcKrLjpo4RhSJx0-j7HveYxJgxGUju2MCwQnSOoa2O39uBXdyjIrKlJzMvTFltexXrEPZ8ZJhmR1BK0ipU2Gb4WhX2R8WbN4KF-q2PYdFzA1tmvE1ywPTyWO6WFEh0DltoBDkx7YnfZ7Zls23KBtdznBdc4nLbHZDAI198ecMbE8HtBOpWP2BDGfc9_ZbTdDL4dcr2KZTTZZqcAZmFNInVJk3Q9qmocd1YV8K4penarEWVODqH2p-sLv6h30BlGIycqWO7D5dwkFPEvatyBeXs7T2poePOomsh7k9EQI9m
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ANTI-CD3+ANTIBODIES%2C+ANTI-CD123+ANTIBODIES+AND+BISPECIFIC+ANTIBODIES+SPECIFICALLY+BINDING+TO+CD3+AND%2FOR+CD123&rft.inventor=LEUSCHNER%2C+Wulf-Dirk&rft.inventor=WONEROW%2C+Peter&rft.inventor=CARREZ%2C+Chantal&rft.inventor=ALBRECHT%2C+Jana&rft.inventor=WETZEL%2C+Marie-C%C3%A9cile&rft.inventor=BARRIERE%2C+C%C3%A9dric&rft.inventor=GUERIF%2C+St%C3%A9phane&rft.inventor=KROLL%2C+Katja&rft.inventor=LANGE%2C+Christian&rft.inventor=SCHNEIDER%2C+Marion&rft.inventor=BEIL%2C+Christian&rft.inventor=LEMOINE%2C+Cendrine&rft.inventor=RAO%2C+Ercole&rft.inventor=BENINGA%2C+Jochen&rft.date=2017-08-30&rft.externalDBID=A&rft.externalDocID=SG11201705925PA